Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of...
שמור ב:
הוצא לאור ב: | Frontiers Research Topics |
---|---|
Main Authors: | , , , |
פורמט: | Livro |
שפה: | Inglês |
יצא לאור: |
Frontiers Media SA
2018
|
נושאים: | |
גישה מקוונת: | https://directory.doabooks.org/handle/20.500.12854/58773 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|